# Trial With Allergic Rhinitis Patients Taking GSK256066 Versus Placebo In A Pollen Challenge Chamber

> **NCT00430157** · PHASE2 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 45 (actual)

## Conditions studied

- Rhinitis, Allergic, Seasonal
- Seasonal Allergic Rhinitis

## Interventions

- **DRUG:** GSK256066

## Key facts

- **NCT ID:** NCT00430157
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2012-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00430157

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00430157, "Trial With Allergic Rhinitis Patients Taking GSK256066 Versus Placebo In A Pollen Challenge Chamber". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00430157. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*